BioSpace News Archive

Katana Pharmaceuticals Inc., a San Francisco-based startup biotech company developing novel treatments for neonatal patient populations and rare pediatric disorders, announced the receipt of the first payment of an up to $1.05 million Innovative Challenge Grant from March of Dimes to develop a novel non-opioid treatment for neonatal abstinence syndrome.*

Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation devices for the treatment of urinary and bowel dysfunction, announced U.S. Food & Drug Administration approval of its new wireless patient Remote Control with SmartMRI™ technology for the Axonics r-SNM® System under a premarket approval supplement.

Distributed Bio, a global leader in computational optimization of fully human monoclonal antibody libraries, is pleased to announce a comprehensive research partnership with Mediar Therapeutics, a preclinical stage biotechnology company developing therapeutics to halt, or even reverse, fibrosis based in Cambridge, MA.

Aurinia Pharmaceuticals Inc. is pleased to announce that the nine incumbent directors of the Company were elected at the Company’s annual general meeting held on June 2, 2020.

Outset Medical, a leading med tech innovator delivering first-of-its-kind technology into the growing global dialysis market, announced the appointment of John Brottem as the company’s new General Counsel.

Epigenetics company Base Genomics launches, based on a new invention to sequence DNA methylation developed at the Ludwig Institute for Cancer Research Branch at the University of Oxford

Karuna Therapeutics, Inc. announced that Steve Paul, M.D., chief executive officer, president and chairman of Karuna Therapeutics, will participate in a fireside chat at the virtual Goldman Sachs Annual Global Healthcare Conference on Thursday, June 11, 2020 at 10:30 a.m. EDT.

New research from Dr. Charles Brenner expands human conditions with disturbed NAD systems including alcohol-related liver disease and other liver diseases.

Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated, is scheduled to speak at the Raymond James 2020 Human Health Innovation Conference on Wednesday, June 17, 2020 at 2:20 p.m..

Mish brings extensive global executive leadership experience in the development, manufacturing and commercialization of active pharmaceutical ingredients, including cannabinoids, and related consumer products